Search Page

1

Cite

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations.

McCurdy CR, Sharma A, Smith KE, Veltri CA, Weiss ST, White CM, Grundmann O. McCurdy CR, et al. Among authors: veltri ca. Expert Rev Clin Pharmacol. 2024 Jan-Jun;17(2):131-142. doi: 10.1080/17512433.2024.2305798. Epub 2024 Jan 29. Expert Rev Clin Pharmacol. 2024. PMID: 38217374 Free PMC article. Review.

Cite

2

Cite

The neuropharmacology of kratom, a novel psychoactive natural product.

Green M, Veltri CA, Prozialeck WC, Grundmann O. Green M, et al. Among authors: veltri ca. Prog Neuropsychopharmacol Biol Psychiatry. 2025 Jan 10;136:111215. doi: 10.1016/j.pnpbp.2024.111215. Epub 2024 Dec 9. Prog Neuropsychopharmacol Biol Psychiatry. 2025. PMID: 39662722 Review.

Cite

3

Cite

The Potential for Kratom as an Antidepressant and Antipsychotic.

Johnson LE, Balyan L, Magdalany A, Saeed F, Salinas R, Wallace S, Veltri CA, Swogger MT, Walsh Z, Grundmann O. Johnson LE, et al. Among authors: veltri ca. Yale J Biol Med. 2020 Jun 29;93(2):283-289. eCollection 2020 Jun. Yale J Biol Med. 2020. PMID: 32607089 Free PMC article. Review.

Cite

4

Cite

Understanding Kratom Use: A Guide for Healthcare Providers.

Swogger MT, Smith KE, Garcia-Romeu A, Grundmann O, Veltri CA, Henningfield JE, Busch LY. Swogger MT, et al. Among authors: veltri ca. Front Pharmacol. 2022 Mar 2;13:801855. doi: 10.3389/fphar.2022.801855. eCollection 2022. Front Pharmacol. 2022. PMID: 35308216 Free PMC article. Review.

Cite

5

Cite

Pharmacokinetics of fluoxetine in horses following oral administration.

Waitt Wolker LH, Veltri CA, Pearman K, Lozoya M, Norris JW. Waitt Wolker LH, et al. Among authors: veltri ca. J Vet Pharmacol Ther. 2022 Jan;45(1):63-68. doi: 10.1111/jvp.13029. Epub 2021 Nov 7. J Vet Pharmacol Ther. 2022. PMID: 34747024

Cite

6

Cite

Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder.

Green M, Veltri CA, Grundmann O. Green M, et al. Among authors: veltri ca. Subst Abuse Rehabil. 2024 Apr 3;15:43-57. doi: 10.2147/SAR.S431270. eCollection 2024. Subst Abuse Rehabil. 2024. PMID: 38585160 Free PMC article. Review.

Cite

7

Cite

Kratom as a potential substance use disorder harm reduction agent.

Green M, Vadiei N, Veltri CA, Grundmann O, Evoy KE. Green M, et al. Among authors: veltri ca. Front Public Health. 2024 May 30;12:1416689. doi: 10.3389/fpubh.2024.1416689. eCollection 2024. Front Public Health. 2024. PMID: 38873312 Free PMC article. Review.

Cite

8

Cite

Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.

Grundmann O, Veltri CA, Morcos S, Smith KE, Singh D, Corazza O, Cinosi E, Martinotti G, Walsh Z, Swogger MT. Grundmann O, et al. Among authors: veltri ca. Exp Clin Psychopharmacol. 2023 Oct;31(5):963-977. doi: 10.1037/pha0000632. Epub 2023 Jan 12. Exp Clin Psychopharmacol. 2023. PMID: 36634016 Free PMC article.

Cite

9

Cite

Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects.

Grundmann O, Hill K, Al Barzanji E, Hazrat NG, Kaur G, Negeve RE, Shade S, Weber S, Veltri CA. Grundmann O, et al. Among authors: veltri ca. J Ethnopharmacol. 2023 Dec 5;317:116779. doi: 10.1016/j.jep.2023.116779. Epub 2023 Jun 24. J Ethnopharmacol. 2023. PMID: 37364801

Cite

10

Cite

Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.

Grundmann O, Smith KE, Prozialeck WC, Veltri CA, Boyer EW. Grundmann O, et al. Among authors: veltri ca. Front Psychiatry. 2024 May 23;15:1411964. doi: 10.3389/fpsyt.2024.1411964. eCollection 2024. Front Psychiatry. 2024. PMID: 38846916 Free PMC article. No abstract available.

Cite